Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Compugen Ltd. - Ordinary Shares
(NQ:
CGEN
)
1.740
-0.050 (-2.79%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Compugen Ltd. - Ordinary Shares
< Previous
1
2
3
4
5
Next >
Compugen Ltd (NASDAQ:CGEN) Reports Q3 2025 Earnings Beat, Stock Rises
↗
November 10, 2025
Compugen (CGEN) Q3 2025 earnings beat estimates, with revenue up 26% and a narrower EPS loss. The stock surged 3.7% pre-market on the strong results.
Via
Chartmill
Topics
Earnings
Earnings Scheduled For November 10, 2025
↗
November 10, 2025
Via
Benzinga
Compugen Ltd (NASDAQ:CGEN) Reports Q2 2025 Revenue and EPS Miss, Shares Drop in Premarket
↗
August 06, 2025
Compugen Ltd (CGEN) misses Q2 2025 revenue and EPS estimates, shares drop 2% premarket. Weak financials and clinical progress concerns weigh on investor sentiment.
Via
Chartmill
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
Earnings Scheduled For May 19, 2025
↗
May 19, 2025
Via
Benzinga
Uncovering Potential: Compugen's Earnings Preview
↗
May 16, 2025
Via
Benzinga
Earnings Scheduled For November 12, 2024
↗
November 12, 2024
Via
Benzinga
Earnings Preview For Compugen
↗
March 04, 2024
Via
Benzinga
5 Analysts Have This to Say About Compugen
↗
August 07, 2023
Via
Benzinga
Compugen Earnings Preview
↗
August 04, 2023
Via
Benzinga
Earnings Scheduled For March 4, 2025
↗
March 04, 2025
Via
Benzinga
CGEN Stock Earnings: Compugen Beats EPS, Beats Revenue for Q2 2024
↗
August 06, 2024
CGEN stock results show that Compugen beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Expert Ratings for Compugen
↗
May 26, 2023
Via
Benzinga
Compugen: Q1 Earnings Insights
↗
May 15, 2023
Via
Benzinga
CGEN Stock Earnings: Compugen Misses EPS, Misses Revenue for Q1 2024
↗
May 20, 2024
CGEN stock results show that Compugen missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
CGEN Stock Earnings: Compugen Misses EPS, Beats Revenue for Q4 2023
↗
March 05, 2024
CGEN stock results show that Compugen missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Earnings Scheduled For March 5, 2024
↗
March 05, 2024
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
Via
Benzinga
7 Speculative Stocks to Double Your Money THIS Year
↗
January 22, 2024
Although terribly risky, these stocks to double your money could be enticing if you have some pocket change lying around.
Via
InvestorPlace
Crude Oil Rises Over 1%; Biodexa Pharmaceuticals Shares Plunge
↗
December 19, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 200 points on Tuesday. The Dow traded up 0.53% to 37,505.25 while the NASDAQ rose 0.51% to 14,980.71. The...
Via
Benzinga
Topics
Stocks
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
December 19, 2023
Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy...
Via
Benzinga
Dow Jumps 150 Points; FactSet Shares Rise After Q1 Results
↗
December 19, 2023
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 150 points on Tuesday. The Dow traded up 0.46% to 37,476.21 while the NASDAQ rose 0.41% to 14,966.74. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Why Is Cancer Immunotherapy-Focused Compugen Stock Is Trading Higher Today?
↗
December 19, 2023
Gilead Sciences Inc (NASDAQ: GILD) announced an agreement with Compugen Ltd (NASDAQ: CGEN) to license its pre-clinical antibody program against IL-18 binding protein exclusively, including the
Via
Benzinga
Why Are Stocks Up Today?
↗
December 19, 2023
Stocks are up today and investors wondering why will want to keep reading as we have a breakdown of the market's rally on Tuesday!
Via
InvestorPlace
Why Is Compugen (CGEN) Stock Up 189% Today?
↗
December 19, 2023
Compugen stock is up on Tuesday as investors in CGEN shares react to an exclusive licensing agreement with Gilead Sciences.
Via
InvestorPlace
US Stocks Higher; Accenture Issues Weak Sales Outlook
↗
December 19, 2023
U.S. stocks traded higher this morning, with the Dow Jones index gaining around more than 50 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.17% to 37,369.84 while the...
Via
Benzinga
Topics
Stocks
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
December 19, 2023
It's time to dive into the biggest pre-market stock movers as we check out all of the most recent news for Tuesday morning!
Via
InvestorPlace
7 Promising Penny Stocks With the Potential to Defy Expectations
↗
December 15, 2023
While market speculation can get extremely dangerous, those who understand the risks may like these high-potential penny stocks.
Via
InvestorPlace
Use Support And Resistance Levels To Avoid Chaos In Your Portfolio
↗
October 28, 2023
A support line is a price level where a stock historically stops declining. It can be a flat line all at one price, or it can be a trend line that gradually moves in one direction. Here is a closer...
Via
Talk Markets
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
↗
March 11, 2023
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the...
Via
Benzinga
Why Compugen Shares Are Up Today
↗
February 28, 2023
The company released its fourth-quarter and full-year results after the bell Monday.
Via
The Motley Fool
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
